Logo-ajmb
Submitted: 12 Jan 2015
Revised: 03 Feb 2015
Accepted: 25 Feb 2015
First published online: 21 Mar 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 2058
PDF Download: 1206
Full Text View: 1332
Avicenna J Med Biochem. 2015;3(1): e26908.
doi:10.17795/ajmb-26908

Research Article

The Effect of Regular Aerobic Training on Tumor Necrosis Factor-Alpha (TNF-α) in Males With Type II Diabetes

Hassan Ghasemalipour 1, Mojtaba Eizadi 2 * , Masoud Hajirasouli 3

1 College of Physical Education and Sport Science, South Tehran Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Physical Education and Sport Science, Saveh Branch, Islamic Azad University, Saveh, IR Iran
3 College of Physical Education and Sport Sciences, Islamshahr Branch, Islamic Azad University, Islamshahr, IR Iran
*Corresponding author: Mojtaba Eizadi, Department of Physical Education and Sport Science, Saveh Branch, Islamic Azad University, Saveh, IR Iran. Tel/Fax: +98-8642333342, Email: izadimojtaba2006@yahoo.com

Abstract

Background: A growing body of literature suggests that systemic inflammation is associated with obesity, type II diabetes and metabolic syndrome.

Objectives: The aim of this study was to evaluate the effect of three months of aerobic training on serum Tumor Necrosis Factor-alpha (TNF-α), as an inflammatory cytokine, in males with type II diabetes.

Patients and Methods: Twenty-four adult obese males aged 38 to 48 years and Body Mass Index (BMI) of 30 to 36 kg/m 2 with type II diabetes were randomly divided to exercise (n = 12) and control (n = 12) groups. The exercise group completed an aerobic training program (for three months, three times/week) and the control group did not participate in the exercise program. Fasting serum TNF-α and all anthropometrical markers were measured before and after the training program. Data was analyzed by independent-paired sample T test.

Results: Exercise training resulted in a significant increase in body weight (P < 0.001), body fat percentage (P < 0.001), BMI (P < 0.001) and abdominal circumference (P < 0.001). There was no significant difference in serum TNF-a before-compared to after-training program (P = 0.83).

Conclusions: Based on these data, we conclude that the aerobic training program does not have an anti-inflammatory property with emphasis on serum TNF-α in type II diabetic patients.

Keywords: Type II diabetes; Inflammation; Aerobic Training; Obesity

1. Background

Cardiovascular Diseases (CVD) are currently among the main causes of death around the globe (1). Lipid abnormalities in the metabolic syndrome and diabetes are the background of this disease. Inflammation caused by increase in inflammatory cytokines in blood circulation is among predictive factors of cardiovascular disease, type 2 diabetes and metabolic syndrome (2). On the other hand, even in younger subjects, obesity and being overweight is associated with an increase in dyslipidemias, hypertension and insulin resistance (3). The increase in adipose tissue leads to physiological and morphological changes such as increase in secretion of pro-inflammatory cytokines (4). Although the physiological mechanisms of insulin resistance and impaired insulin secretion, that are the main determinants of type 2 diabetes (5-7), are completely unknown, clinical studies have alluded to the pivotal role of increasing markers or inflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-α) (8, 9). Increase in adiponectin expression in terms of increase in TNF-α has also been reported (10). Increase in TNF-α systemic level is known as an inflammatory marker in fat individuals, and weight loss has been introduced as a key intervention to reduce its plasma concentration (10, 11). Scientific findings on TNF-α response to exercise are inconsistent. However, in another study, TNF-α was decreased significantly in skeletal muscle of elderly subjects following exercise (12). In some studies, interventions such as exercise, weight loss, and dietary or antioxidants consumption, to reduce inflammatory cytokines, in patients with diabetes have been studied (10). In support of these findings, 12-week endurance training led to a reduction in inflammatory cytokine expression (13). However, in a recent study, after 12 weeks of exercise, while TNF-α level remained unchanged a significant decrease in C-Reactive Protein (CRP) levels was observed in obese individuals (14). Some other studies also showed no change in TNF-α by exercise training when compared to the baseline (15, 16).

2. Objectives

Regarding the inconsistent findings in this field, the current study aimed to determine the long-term effects of aerobic exercise (three months) on serum levels of this proinflammatory cytokine in males with type II diabetes.

3. Patients and Methods

3.1. Human Subjects

The participants were twenty-four adult obese subjects aged 43 ± 4 years (Body Mass Index (BMI) of 31.4 ± 1.6 kg/m2) with type II diabetes, who were selected by accessible sampling, and were divided randomly to exercise (n = 12) and control (n = 12) groups. This experimental study was approved by the Ethics Committee of Islamic Azad University, South Tehran Branch, Iran. All subjects completed the consent process and provided written informed consents prior to randomization.


3.2. Inclusion and Exclusion Criteria

Subjects of both groups were inactive, non-smokers and non-alcoholics. Inclusion criteria for the study group were as follows; existing type 2 diabetes for at least three years, being between the age of 30 and 50 years, and having a BMI of 30 or above. A detailed history and physical examination of each subject was obtained. None of the participants had been involved in exercise training or a controlled diet within the previous six months. Those with self-reported physician-diagnosed metabolic disorders such as cardiovascular or cardiorespiratory diseases, hypertension, cancer or fatty liver were excluded. Subjects who were unable to avoid taking drugs for 12 hours before blood sampling were excluded.


3.3. Anthropometry

Anthropometrical measurements were performed before and after the exercise program. Body weight, height, waist circumference and percentage of body fat measurements were obtained by standard methods. Body weight was measured following overnight fasting. Height of the barefoot subject was measured twice to ± 0.2 cm. Body Mass Index was calculated as weight (kg) divided by squared height (m). Abdominal and hip circumferences were measured with a non-elastic tape and the ratio between them (AHO) was calculated. Body fat percentage was estimated by the bioelectrical impedance method (Omron Body Fat Analyzer, Finland).


3.4. Blood sampling and Exercise Protocol

Venous blood was collected from subjects after an overnight fast between 8:00 am and 9:00 am. Blood samples were used to assay glucose, insulin and serum TNF-α for all participants. The subjects were advised to avoid any physical activity or exercise 48 hours before blood sampling. Homeostasis Model Assessment (HOMA) index was calculated using the insulin resistance formula as the product of fasting plasma glucose (mM) and insulin (µU/mL) divided by the constant 22.5. All blood samples were separated by centrifugation and aliquots were frozen at -80˚C until assayed. The Enzyme Linked Immunosorbent Assay (ELISA) reader method (SCO GmbH Reader MPR 1, SCO, Germany) was used to determine serum TNF-α (Human TNF-α Kit, Biovendor, Austria). The Intra- assay coefficient of variation and sensitivity of the method were 5.0% and 6 pg/mL, respectively. All measurements were repeated 48 hours after the last exercise session. The exercise program lasted three months (three times/week) with the exercise intensity between 60% and 80% of the age-predicted maximum heart rate. Each session lasted 45 to 60 minutes and included 15 minutes of warm up and flexible exercises and continued with 30 to 40 minutes of aerobic exercise (running on a treadmill and stationary cycling) and 5 to 10 minutes of cool down at the end. In each session, the intensity was controlled and monitored using the Polar heart rate tester. During this 12-week period, participants in the control group did not participate in any exercise training.


3.5. Data Analysis

The Statistical Package for Social Sciences (SPSS) for Windows was used for statistical analysis. The normality of the variables was determined by the Kolmogorov-Smirnov test. To compare anthropometrical markers and serum TNF-α between the two groups at baseline, the independent sample T-test was used. Difference in each variable pre and post training was compared using the Student’s paired t-test. A P value of < 0.05 was accepted as significant in two-tailed tests.

4. Results

As mentioned previously, in this study, we investigated the effect of three months of an aerobic exercise program on serum TNF-α in non-trained adult men with type II diabetes. At baseline, the patients had fasting glucose (218 ± 42 mg/dL), serum insulin (8.34 ± 1.15 µIU/mL) and insulin resistance (4.43 ± 0.78). Baseline and post training anthropometrical indexes and clinical characteristics of the two groups are shown in Table 1. All data are presented by means and standard deviations. Based on the independent t-test analysis, no significant differences were found in serum TNF-α and all anthropometrical markers between exercise and control groups at baseline. Exercise training resulted in a significant decrease in body weight (P < 0.001), BMI (P < 0.001), body fat percentage (P < 0.001), abdominal circumference (P < 0.001) and other anthropometrical markers. There was no significant difference in serum TNF-α pre and post-training (P = 0.83). On the other hand, the aerobic exercise program was not associated with significant changes in serum TNF-α in the studied patients.

Table 1.
Means and Standard Deviations of Anthropometrical Markers and Serum TNF-α Before and After the Intervention a, b

5. Discussion

The findings of the present study showed that three months of aerobic exercise does not affect serum TNF-α as the pro-inflammatory cytokine in males with type II diabetes. Scientific studies support the pathophysiological role of TNF-α in atherosclerosis and cardiovascular disease. Some researchers have noted that insulin resistance is one of the main factors that increases inflammatory cytokine secretion in obese subjects (17). Insulin resistance is also inversely correlated with serum adiponectin, as anti-inflammatory cytokines, in type II diabetic patients (18). The prevalence of obesity in patients with type 2 diabetes mellitus has been reported in both developed and developing country (19). The change in TNF-α expression in adipose tissue is directly related to the rate of obesity and hyperinsulinemia levels (20, 21). Increased levels of other inflammatory adipokines such as leptin in obese patients with type II diabetes compared to non-obese patients with type II diabetes was reported by another previous study (22). Obesity is associated with higher levels of TNF-α (23). Studies on both obese humans and animals have pointed out that an increase in the secretion of TNF-α by adipose tissue is associated with a decrease in insulin sensitivity (20, 24). On the other hand, weight loss in healthy or sick obese individuals is associated with reduction of TNF-α secretion and insulin resistance (25). However, in this study, a three-month aerobic exercise program did not significantly change serum levels of TNF-α in patients with diabetes. Although some previous studies have alluded to a significant reduction in TNF-α and other inflammatory cytokines in response to long-term training programs (26-28), yet in line with the present study, some recent studies have reported no change in this inflammatory cytokine following long-term training program in healthy or sick obese individuals (29, 30). For example, in one study, a 12-month exercise program did not lead to changes in TNF-α, adiponectin and triglyceride levels in obese subjects (31). Furthermore, findings of a recent study showed 16 weeks of rapid walking led to an increase in serum levels of TNF-α in the absence of change in IL-6 and adiponectin in obese and overweight individuals (32). Regarding the effect of long-term training on the level of cytokines in obese populations (healthy or sick), some previous studies have noted that inflammatory or anti-inflammatory cytokines improvement is possible only if the training program is associated with a significant reduction in body weight (weight loss) (33). In addition to anti-inflammatory properties, the results of a recent study showed that aerobic exercise, as a stimulus, can change the levels of matrix metalloproteinases and their tissue inhibitors in order to prevent cardiovascular diseases in patients with diabetes (34). However, in this study, although the three-month aerobic exercise program caused significant reduction in body weight, and other anthropometric markers and body composition indicators, such as percentage of body fat in studied subjects, yet it did not lead to a significant change in serum levels of TNF-α. In this context, although the findings of this study is somewhat surprising and controversial, but some previous studies also reported no change in TNF-α or other inflammatory cytokines following a long-term training program, even in the presence of weight loss (35, 36). On the other hand, some other studies have reported that at least a 10% reduction in body weight is necessary for improvement of inflammatory or anti-inflammatory cytokines (37). However, there is no general consensus on determining the effect of different training programs on inflammatory cytokines in patients with type II diabetes or other obese individuals, healthy or sick. Regarding to the inconsistency in findings of studies in this area, the researchers found that the differences in study results are related to variations in the type of training program or measurement tools, weight changes, sampling time, initial fitness level, changes in plasma volume and type of population studied (38, 39). However, it should also be noted that exercise could lead to local anti-inflammatory effects in skeletal muscles but not in circulating levels (40). It is also possible that despite no change in systemic levels of inflammatory cytokines, exercise training is associated with decreased expression of this cytokine. Although some previous studies support the anti-inflammatory effect of long-term aerobic training on healthy or sick obese individuals, yet the finding of our study showed that serum TNF-α, as a pro-inflammatory cytokine, remained without change after three months of aerobic training in adult males with type II diabetes. It seems that inconsistency in findings of this study with other previous studies is due to differences in the types of protocols, duration, intensity and frequency of exercise sessions or initial fitness level of studied subjects. Further studies are necessary to elucidate the significance of exercise training, as an anti-inflammatory intervention, in patients with diabetes or other obesity-related disease.

Acknowledgments

We are particularly grateful to all subjects who participated in this study. We thank the Research Deputy of the Islamic Azad University, South Tehran Branch for their financial support and cooperation in implementing this project.

Footnotes

Authors’ Contributions: Study concept and design: Hassan Ghasemalipour. Drafting of the manuscript: Mojtaba Eizadi. Statistical analysis: Masoud Hajirasouli. Administrative, technical, and material support: Mojtaba Eizadi.
Funding/Support: This research was supported by the Islamic Azad University, South Tehran Branch, Tehran, Iran.

References

  • 1. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107(17):2185-9. [DOI] [PubMed]
  • 2. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115-26. [DOI] [PubMed]
  • 3. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000. Diabetes Care. 2004;27(10):2438-43. [PubMed]
  • 4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AJ. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808. [DOI] [PubMed]
  • 5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607. [PubMed]
  • 6. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37(6):667-87. [PubMed]
  • 7. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38(12):1512-27. [PubMed]
  • 8. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 2002;51(10):2929-35. [PubMed]
  • 9. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-34. [PubMed]
  • 10. Puglisi MJ, Fernandez ML. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr. 2008;138(12):2293-6. [DOI] [PubMed]
  • 11. Weiss ST. Obesity: insight into the origins of asthma. Nat Immunol. 2005;6(6):537-9. [DOI] [PubMed]
  • 12. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001;15(2):475-82. [DOI] [PubMed]
  • 13. Lambert CP, Wright NR, Finck BN, Villareal DT. Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol (1985). 2008;105(2):473-8. [DOI] [PubMed]
  • 14. Sharman MJ, Volek JS. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond). 2004;107(4):365-9. [DOI] [PubMed]
  • 15. Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc. 2008;56(4):644-51. [DOI] [PubMed]
  • 16. Puglisi MJ, Vaishnav U, Shrestha S, Torres-Gonzalez M, Wood RJ, Volek JS, et al. Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines. Lipids Health Dis. 2008;7:14. [DOI] [PubMed]
  • 17. Bal Y, Adas M, Helvaci A. Evaluation of the relationship between insulin resistance and plasma tumor necrosis factor-alpha, interleukin-6 and C-reactive protein levels in obese women. Bratisl Lek Listy. 2010;111(4):200-4. [PubMed]
  • 18. Osho O, Akinbo S, Osinubi A, Olawale O. Effect of Progressive Aerobic and Resistance Exercises on the Pulmonary Functions of Individuals with type 2 diabetes in Nigeria. Int J Endocrinol Metab. 2012;10(1):411-7. [DOI]
  • 19. Izadi M, Goodarzi MT, Khalaj HS, Khorshidi D, Doali H. Serum Adiponectin Levels are Inversely Correlated with Insulin Resistance in Obese Men with Type 2 Diabetes. Int J Endocrinol Metab. 2011;9(2):253-7. [DOI]
  • 20. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91. [PubMed]
  • 21. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95(5):2409-15. [DOI] [PubMed]
  • 22. Mohiti J, Afkhami M, Babaei A. Relation between leptin and insulin in patients with type II diabetes mellitus. Int J Endocrinol Metab. 2005;3(3):121-5.
  • 23. Warne JP. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol. 2003;177(3):351-5. [PubMed]
  • 24. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 1994;134(1):264-70. [DOI] [PubMed]
  • 25. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83(8):2907-10. [DOI] [PubMed]
  • 26. Zwetsloot KA, John CS, Lawrence MM, Battista RA, Shanely RA. High-intensity interval training induces a modest systemic inflammatory response in active, young men. J Inflamm Res. 2014;7:9-17. [DOI] [PubMed]
  • 27. Ho SS, Dhaliwal SS, Hills AP, Pal S. Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation. 2013;36(3):625-32. [DOI] [PubMed]
  • 28. Abd El-Kader MS, Al-Jiffri O, Ashmawy EM. Impact of weight loss on markers of systemic inflammation in obese Saudi children with asthma. Afr Health Sci. 2013;13(3):682-8. [DOI] [PubMed]
  • 29. Auerbach P, Nordby P, Bendtsen LQ, Mehlsen JL, Basnet SK, Vestergaard H, et al. Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men. Am J Physiol Regul Integr Comp Physiol. 2013;305(5):R490-8. [DOI] [PubMed]
  • 30. Wenning P, Kreutz T, Schmidt A, Opitz D, Graf C, Voss S, et al. Endurance exercise alters cellular immune status and resistin concentrations in men suffering from non-insulin-dependent type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121(8):475-82. [DOI] [PubMed]
  • 31. Bouchonville M, Armamento-Villareal R, Shah K, Napoli N, Sinacore DR, Qualls C, et al. Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial. Int J Obes (Lond). 2014;38(3):423-31. [DOI] [PubMed]
  • 32. Riesco E, Tessier S, Lacaille M, Perusse F, Cote M, Despres JP, et al. Impact of a moderate-intensity walking program on cardiometabolic risk markers in overweight to obese women: is there any influence of menopause? Menopause. 2013;20(2):185-93. [DOI] [PubMed]
  • 33. Nayak BS, Ramsingh D, Gooding S, Legall G, Bissram S, Mohammed A, et al. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Prim Care Diabetes. 2010;4(3):187-92. [DOI] [PubMed]
  • 34. Dastani M, Rashidlamir A, Alizadeh A. Effects of 8 Weeks of Aerobic Exercise on Matrix Metalloproteinase-9 and Tissue Inhibitor Levels in Type II Diabetic Women. Zahedan J Res Med Sci. 2014;16(6):12-5.
  • 35. Cavagnolli DA, Esteves AM, Ackel-D'Elia C, Maeda MY, de Faria AP, Tufik S, et al. Aerobic exercise does not change C-reactive protein levels in non-obese patients with obstructive sleep apnoea. Eur J Sport Sci. 2014;14 Suppl 1:S142-7. [DOI] [PubMed]
  • 36. Lebon J, Riesco E, Tessier D, Dionne IJ. Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: a randomized controlled trial. Menopause. 2014;21(8):869-75. [DOI] [PubMed]
  • 37. Johnson WD, Brashear MM, Gupta AK, Rood JC, Ryan DH. Incremental weight loss improves cardiometabolic risk in extremely obese adults. Am J Med. 2011;124(10):931-8. [DOI] [PubMed]
  • 38. Bouassida A, Chamari K, Zaouali M, Feki Y, Zbidi A, Tabka Z. Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med. 2010;44(9):620-30. [DOI] [PubMed]
  • 39. Kraemer RR, Aboudehen KS, Carruth AK, Durand RT, Acevedo EO, Hebert EP, et al. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc. 2003;35(8):1320-5. [DOI] [PubMed]
  • 40. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;42(5):861-8. [PubMed]